New Antifungal Drugs, New Approaches and Vaccines

Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis

Phase 3

20 May 2016

Evaluation of the Potential for Cytochrome P450 3A4 Inhibition by F901318 Using Oral Midazolam as a Probe

Phase 1

4 April 2016

Phase 1 Trial Of Antifungal Drug (VL-2397) Targeting Invasive Aspergillosis

Phase 1

7 March 2016

Life sciences firm inks licensing deal with Merck

26 February 2016

Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis.

22 February 2016

FDA OKs Another Topical Drug for Onychomycosis (Kerydin)

9 February 2014

Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With Onychomycosis

Phase 2

15 May 2008

Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

Phase 3

21 February 2011

Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

Phase 3

7 January 2011

Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)

Phase 2

15 May 2008